BPG is committed to discovery and dissemination of knowledge
Case Report
Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.
World J Hepatol. Apr 27, 2026; 18(4): 117993
Published online Apr 27, 2026. doi: 10.4254/wjh.v18.i4.117993
Tumor necrosis factor receptor superfamily member 13B mutation-associated chronic cholangitis with cirrhosis: A case report and review of literature
Ying Zhou, Qi-Jiao Cheng, Ming-Xing Liang, Su-Qun Li, Yu-Zhi Su, Yong-Ming Cai, Zong-Qin Pan, Yu-Xin Xie, Ying-Hua Chen, Yi-Huai He
Ying Zhou, Qi-Jiao Cheng, Ming-Xing Liang, Su-Qun Li, Yu-Zhi Su, Yu-Xin Xie, Ying-Hua Chen, Yi-Huai He, Department of Infectious Diseases, Affiliated Hospital of Zunyi Medical University, Zunyi 563000, Guizhou Province, China
Yong-Ming Cai, Department of Infectious Diseases, People’s Hospital of Renhuai City, Zunyi 563000, Guizhou Province, China
Zong-Qin Pan, Department of Infectious Diseases, People’s Hospital Qiandongnan Miao and Dong Autonomous Prefecture, Kaili 556000, Guizhou Province, China
Co-first authors: Ying Zhou and Qi-Jiao Cheng.
Co-corresponding authors: Ying-Hua Chen and Yi-Huai He.
Author contributions: Zhou Y and Cheng QJ contributed equally to this work; Zhou Y, Cheng QJ, Liang MX, Li SQ, Su YZ, Cai YM, and Xie YX collected medical history; Zhou Y, Cheng QJ, and Pan ZQ summarized and analyzed the medical history data; He YH, Chen YH, and Zhou Y conceived and designed the content of the article; Zhou Y and Cheng QJ wrote the initial paper; He YH, Chen YH, Cai YM, Pan ZQ, and Xie YX revised the paper; He YH had primary responsibility for the final content; and all authors read and approved the final manuscript.
Supported by Science and Technology Planning Projects of Guizhou Province, No. QKHJC-MS(2025)384 and No. QKHJC-MS(2025)392; Health Research Project of Guizhou Province, No. gzwkj2024-103 and No. gzwkj2024-324; Scientific Research Project of the Guizhou Provincial Bureau of Traditional Chinese Medicine, No. QZYY-2023-021; and Beijing Liver and Gallbladder Mutual Aid Public Welfare Foundation Artificial Liver Special Fund, No. iGandanF-1082024-RGG018.
Informed consent statement: Written informed consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: All authors declare that they have no conflict of interest to disclose.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Corresponding author: Yi-Huai He, MD, Department of Infectious Diseases, Affiliated Hospital of Zunyi Medical University, No. 201 Dalian Street, Zunyi 563000, Guizhou Province, China. 993565989@qq.com
Received: December 22, 2025
Revised: January 19, 2026
Accepted: February 13, 2026
Published online: April 27, 2026
Processing time: 122 Days and 3.4 Hours
Abstract
BACKGROUND

The transmembrane activator and calcium-modulator and cyclophilin ligand interactor, encoded by tumor necrosis factor receptor superfamily member 13B (TNFRSF13B), maintains immune homeostasis through bidirectional regulation of B-cell function. This study presents a case of a 56-year-old female with chronic cholangitis and cirrhosis associated with a heterozygous missense mutation in TNFRSF13B.

CASE SUMMARY

A 56-year-old female with thalassemia trait and recurrent ascending cholangitis following cholangiojejunostomy presented with cirrhosis of unclear etiology. Despite serial hospitalizations for cholestatic decompensation and comprehensive evaluations-including serological profiling with elevated antinuclear antibody titers and histopathological assessment-no conventional cirrhosis triggers were identified. The patient presented with elevated serum immunoglobulin A (IgA) and IgG, and no apparent immune dysfunction. Two magnetic resonance imaging examinations revealed absence of the left hepatic lobe and gallbladder, no dilation of intrahepatic bile ducts, and inflammatory lesions in the hepatic hilum, cirrhosis, and splenomegaly. Pathological review of the resected left hepatic lobe demonstrated extensive plasma cell infiltration (MUM1+/IgG+) with focal iron deposits. Whole-exome sequencing uncovered a heterozygous missense variant (c.436G>C, p.Ala146Pro) in TNFRSF13B. She was diagnosed with TNFRSF13B mutation-associated chronic cholangitis and cirrhosis. Treatment with antibiotics, hepatoprotective drugs, and ursodeoxycholic acid led to symptom resolution, and she was discharged with ongoing therapy.

CONCLUSION

TNFRSF13B mutation may impair B-cell negative regulation, promoting cholangitis, and cirrhosis. Iron overload and bacterial infection accelerate disease progression.

Keywords: Autoimmune liver disease; Chronic cholangitis; TNFRSF13B gene; B cell homeostasis; Case report

Core Tip: Tumor necrosis factor receptor superfamily member 13B (TNFRSF13B) maintains immune homeostasis through bidirectional regulation of B cell function. This case report presents a case where a TNFRSF13B mutation that may impair TACI’s negative regulatory control over B cell activity, causing B cell hyperactivation, sustained local inflammatory responses, and chronic cholangitis progressing to cirrhosis. This finding provides a novel immunogenetic perspective for understanding certain autoimmune liver diseases of unknown etiology.